ID   170-MG-BA
AC   CVCL_LM81
SY   170MGBA
DR   DepMap; ACH-002680
DR   DSMZ; ACC-804
DR   DSMZCellDive; ACC-804
DR   Wikidata; Q54582330
RX   PubMed=30509096;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 24 hours (PubMed=30509096); ~40-60 hours (DSMZ=ACC-804).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (DepMap=ACH-002680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Thr (c.832C>A); ClinVar=VCV000376643; Zygosity=Homozygous (DepMap=ACH-002680).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): DSMZ=ACC-804
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D18S51: 12,19
ST   D19S433: 14,15
ST   D21S11: 31,31.2
ST   D2S1338: 20
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 23,25
ST   Penta D: 11,12
ST   Penta E: 17
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 15,20
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
RX   PubMed=30509096; DOI=10.4149/neo_2018_180427N278;
RA   MacLeod, Roderick A.F.
RA   Schneider, Bjorn
RA   Sivakova, Ivana
RA   Nagel, Stefan
RA   Dirks, Wilhelm Gerhard
RA   Mraz, Peter
RA   Kubikova, Eliska
RA   Perzelova, Anna
RT   "High level EGFR amplification in a newly established glioblastoma
RT   cell line 170-MG-BA.";
RL   Neoplasma 66:109-117(2019).
//